CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.
Guillonneau C, Hill M, Hubert FX, Chiffoleau E, Hervé C, Li XL, Heslan M, Usal C, Tesson L, Ménoret S, Saoudi A, Le Mauff B, Josien R, Cuturi MC, Anegon I.
Guillonneau C, et al. Among authors: heslan m.
J Clin Invest. 2007 Apr;117(4):1096-106. doi: 10.1172/JCI28801.
J Clin Invest. 2007.
PMID: 17404623
Free PMC article.